CHICAGO, Sept. 13, 2017 -- Amlan International, a leader in intestinal health in the global animal health and nutrition industry announces that Dr. Margie D. Lee, Professor of Population Health & Diagnostic Laboratory Director, Poultry Diagnostic and Research Center & College of Veterinary Medicine at The University of Georgia, will speak at their Global Sales Meeting on Wednesday, September 13th. Her presentation will focus on bacterial pathogenesis and potential mechanisms of antibiotic alternatives in poultry production.
Dr. Lee’s research is focused on epidemiology of meat and poultry-borne food safety pathogens, microbial pathogenesis, and ecology of poultry intestinal microbiome. Her research has been featured in 77 peer-reviewed publications as well as chapters in the Merck Veterinary Manual and the Laboratory Manual for Isolation.
Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated, “We are excited to have Dr. Lee address our team. I am confident that her industry experience will provide helpful insight in communicating with our customers.”
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation and doing business as “Amlan International”, has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com.
Media Contact
Reagan B. Culbertson
312.706.3256
[email protected]


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



